New anti-angiogenesis agents: review of the clinical experience with carboxyamido-triazole (CAI), thalidomide, TNP-470 and interleukin-12.

Abstract:

:Angiogenesis was postulated to be a critical prognostic factor and therapeutic focus for malignancy more than two decades ago. Recent studies indicate quantitative assessments of microvessel count to be an independent prognostic variable for disease-free and overall survival in a wide variety of tumors, and that angiogenesis may be a feasible target against which to intervene pharmacologically. Several new and old agents have been found to have anti-angiogenic activity and have reached clinical trial. This review will focus on four agents under investigation in the US: carboxyamido-triazole (CAI), thalidomide, TNP-470 and interleukin (IL)-12. CAI, originally identified for its anti-invasive capacity, has been shown to inhibit tumor and endothelial cell proliferation by inhibition of calcium uptake. It is administered orally, is generally well tolerated, and has been shown to induce disease stabilization and occasional reductions in tumor mass. Thalidomide was shown to inhibit growth factor-induced neovessel formation, a process that can also explain its earlier devastating clinical toxicity. It is administered orally, and is currently in phase II clinical trials for prostate cancer, glioblastoma multiforme and breast cancer. TNP-470 is a fumagillin analog that has been shown in in vivo models to be a potent inhibitor of angiogenesis at concentrations that are cytostatic to endothelial cells and tumor cells. Lastly, IL-12 may exert its anti-angiogenic effects through activation of interferon-gamma to up-regulate interferon-inducible protein-10, an anti-angiogenic cytokine. Phase I clinical trials of IL-12 have shown disease stabilization in several tumor types in response to s.c. administration or using genetically engineered IL-12-expressing patient fibroblasts. These promising new agents join the matrix metalloproteinase inhibitors as important new drugs in the anti-cancer armamentarium.

journal_name

Angiogenesis

journal_title

Angiogenesis

authors

Masiero L,Figg WD,Kohn EC

doi

10.1023/A:1018301031580

subject

Has Abstract

pub_date

1997-01-01 00:00:00

pages

23-35

issue

1

eissn

0969-6970

issn

1573-7209

pii

170002

journal_volume

1

pub_type

杂志文章
  • Tumor-derived microRNA-494 promotes angiogenesis in non-small cell lung cancer.

    abstract::Angiogenesis, a crucial step in tumor growth and metastasis, is regulated by various pro- or anti-angiogenic factors. Recently, microRNAs have been shown to modulate angiogenic processes by modulating the expression of critical angiogenic factors. However, roles of tumor-derived microRNAs in regulating tumor vasculari...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-015-9474-5

    authors: Mao G,Liu Y,Fang X,Liu Y,Fang L,Lin L,Liu X,Wang N

    更新日期:2015-07-01 00:00:00

  • Tumor vasculogenic mimicry predicts poor prognosis in cancer patients: a meta-analysis.

    abstract:BACKGROUND:Vasculogenic mimicry (VM) is the formation of vascular channels by tumor cells or tumor cell-derived, trans-differentiated cells in highly aggressive, solid tumors. However, the disease features and prognostic value of VM for overall survival of cancer patients remain controversial. METHOD:To systematically...

    journal_title:Angiogenesis

    pub_type: 杂志文章,meta分析

    doi:10.1007/s10456-016-9500-2

    authors: Yang JP,Liao YD,Mai DM,Xie P,Qiang YY,Zheng LS,Wang MY,Mei Y,Meng DF,Xu L,Cao L,Yang Q,Yang XX,Wang WB,Peng LX,Huang BJ,Qian CN

    更新日期:2016-04-01 00:00:00

  • In situ validation of VEGFR-2 and α v ß 3 integrin as targets for breast lesion characterization.

    abstract::Vascular endothelial growth factor receptor 2 (VEGFR-2) and α v ß 3 integrin are the most frequently addressed targets in molecular imaging of tumor angiogenesis. In preclinical studies, molecular imaging of angiogenesis has shown potential to detect and differentiate benign and malignant lesions of the breast. Thus, ...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-016-9499-4

    authors: Ehling J,Misiewicz M,von Stillfried S,Möckel D,Bzyl J,Pochon S,Lederle W,Knuechel R,Lammers T,Palmowski M,Kiessling F

    更新日期:2016-04-01 00:00:00

  • Marked elevation of vascular endothelial growth factor and basic fibroblast growth factor in pericardial fluid of patients with angina pectoris.

    abstract::Although we reported that basic fibroblast growth factor (bFGF) levels in pericardial fluid of patients with unstable angina are apparently increased, it was unclear whether vascular endothelial growth factor (VEGF) is also increased in patients with myocardial ischemia. Using an enzyme-linked immunosorbent assay, we ...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1023/a:1009062712441

    authors: Fujita M,Ikemoto M,Tanaka T,Tamaki S,Yamazato A,Sawamura T,Hasegawa K,Kihara Y,Nohara R,Sasayama S

    更新日期:1998-01-01 00:00:00

  • Activin receptor-like kinase 1 is associated with immune cell infiltration and regulates CLEC14A transcription in cancer.

    abstract::Cancer cells sustain their metabolic needs through nutrients and oxygen supplied by the bloodstream. The requirement for tumor angiogenesis has been therapeutically exploited in the clinical setting mainly by means of inhibition of the vascular endothelial growth factor family of ligands and receptors. Despite promisi...

    journal_title:Angiogenesis

    pub_type: 临床试验,杂志文章

    doi:10.1007/s10456-018-9642-5

    authors: Bocci M,Sjölund J,Kurzejamska E,Lindgren D,Marzouka NA,Bartoschek M,Höglund M,Pietras K

    更新日期:2019-02-01 00:00:00

  • Influence of the oxygen microenvironment on the proangiogenic potential of human endothelial colony forming cells.

    abstract::Therapeutic angiogenesis is a promising strategy to promote the formation of new or collateral vessels for tissue regeneration and repair. Since changes in tissue oxygen concentrations are known to stimulate numerous cell functions, these studies have focused on the oxygen microenvironment and its role on the angiogen...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-009-9152-6

    authors: Decaris ML,Lee CI,Yoder MC,Tarantal AF,Leach JK

    更新日期:2009-01-01 00:00:00

  • Inhibition of B16 melanoma growth in vivo by retroviral vector-mediated human ribonuclease inhibitor.

    abstract::Human ribonuclease inhibitor (hRI) can inhibit angiogenesis by reversibly binding angiogenin, a member of the RNaseA superfamily, and by suppressing the expression of basic fibroblast growth factor (bFGF). Angiogenesis is necessary for the growth and metastasis of tumors. To study the links between hRI, angiogenesis, ...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-005-5714-4

    authors: Wang T,Yang M,Chen J,Watkins T,Xiuyun C

    更新日期:2005-01-01 00:00:00

  • Plants and their active compounds: natural molecules to target angiogenesis.

    abstract::Angiogenesis, or new blood vessel formation, is an important process in the pathogenesis of several diseases and thus has been targeted for the prevention and treatment for many disorders. However, the anti-angiogenic agents that are currently in use are mainly synthetic compounds and humanized monoclonal antibodies, ...

    journal_title:Angiogenesis

    pub_type: 杂志文章,评审

    doi:10.1007/s10456-016-9512-y

    authors: Lu K,Bhat M,Basu S

    更新日期:2016-07-01 00:00:00

  • Are antiangiogenics a good 'partner' for immunotherapy in ovarian cancer?

    abstract::Ovarian cancer (OC) is associated with poor survival because there are a limited number of effective therapies. Two processes key to OC progression, angiogenesis and immune evasion, act synergistically to promote tumor progression. Tumor-associated angiogenesis promotes immune evasion, and tumor-related immune respons...

    journal_title:Angiogenesis

    pub_type: 杂志文章,评审

    doi:10.1007/s10456-020-09734-w

    authors: García-Martínez E,Redondo A,Piulats JM,Rodríguez A,Casado A

    更新日期:2020-11-01 00:00:00

  • Contrasting effects of sunitinib within in vivo models of metastasis.

    abstract::Sunitinib is a potent and clinically approved tyrosine kinase inhibitor that can suppress tumour growth by inhibiting angiogenesis. However, conflicting data exist regarding the effects of this drug on the growth of metastases in preclinical models. Here we use 4T1 and RENCA tumour cells, which both form lung metastas...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-012-9291-z

    authors: Welti JC,Powles T,Foo S,Gourlaouen M,Preece N,Foster J,Frentzas S,Bird D,Sharpe K,van Weverwijk A,Robertson D,Soffe J,Erler JT,Pili R,Springer CJ,Mather SJ,Reynolds AR

    更新日期:2012-12-01 00:00:00

  • Transcriptional profiling of human microvascular endothelial cells in the proliferative and quiescent state using cDNA arrays.

    abstract::Endothelial cells are known to be a rich source of transcriptional gene expression. Recent technological advances now permit the detailed profiling of mRNA expression using arrays of known cDNAs on blots. We have used such arrays to examine expression of mRNA by primary isolates of human foreskin microvascular endothe...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1023/a:1009085422384

    authors: Zhang HT,Gorn M,Smith K,Graham AP,Lau KK,Bicknell R

    更新日期:1999-01-01 00:00:00

  • Vascular development in endometriosis.

    abstract::Endometriosis, defined as the presence of endometrial tissue outside the uterus, is an estrogen-dependent disease which causes pelvic pain and subfertility in women of reproductive age. The condition has a dramatic impact on the professional, social and marital life of sufferers. Direct and indirect evidence suggests ...

    journal_title:Angiogenesis

    pub_type: 杂志文章,评审

    doi:10.1007/s10456-005-9005-x

    authors: Groothuis PG,Nap AW,Winterhager E,Grümmer R

    更新日期:2005-01-01 00:00:00

  • To be or not to be: endothelial cell plasticity in development, repair, and disease.

    abstract::Endothelial cells display an extraordinary plasticity both during development and throughout adult life. During early development, endothelial cells assume arterial, venous, or lymphatic identity, while selected endothelial cells undergo additional fate changes to become hematopoietic progenitor, cardiac valve, and ot...

    journal_title:Angiogenesis

    pub_type: 杂志文章,评审

    doi:10.1007/s10456-020-09761-7

    authors: Greenspan LJ,Weinstein BM

    更新日期:2021-01-15 00:00:00

  • The role of the fibrinolytic system in corneal angiogenesis.

    abstract::The plasminogen activation system has been implicated in angiogenesis and angiogenesis-dependent diseases such as cancer, atherosclerosis and ocular diseases. The identification and development of inhibitors of angiogenesis offer new possibilities for the treatment of these diseases. To clarify the role of proteins in...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1023/B:AGEN.0000029414.24060.fe

    authors: Vogten JM,Reijerkerk A,Meijers JC,Voest EE,Borel Rinkes IH,Gebbink MF

    更新日期:2003-01-01 00:00:00

  • Shear stress-induced transcriptional regulation via hybrid promoters as a potential tool for promoting angiogenesis.

    abstract::Among the key effects of fluid shear stress on vascular endothelial cells is modulation of gene expression. Promoter sequences termed shear stress response elements (SSREs) mediate the responsiveness of endothelial genes to shear stress. While previous studies showed that shear stress responsiveness is mediated by a s...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-009-9143-7

    authors: Silberman M,Barac YD,Yahav H,Wolfovitz E,Einav S,Resnick N,Binah O

    更新日期:2009-01-01 00:00:00

  • Contrast-enhanced molecular ultrasound differentiates endoglin genotypes in mouse embryos.

    abstract::Targeted ultrasound contrast imaging has the potential to become a reliable molecular imaging tool. A better understanding of the quantitative aspects of molecular ultrasound technology could facilitate the translation of this technique to the clinic for the purposes of assessing vascular pathology and detecting indiv...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-014-9447-0

    authors: Denbeigh JM,Nixon BA,Lee JJ,Jerkic M,Marsden PA,Letarte M,Puri MC,Foster FS

    更新日期:2015-01-01 00:00:00

  • CM101 stimulates cutaneous wound healing through an anti-angiogenic mechanism.

    abstract::CM101, an anti-pathoangiogenic polysaccharide derived from group B streptococcus, has been shown to inhibit inflammatory angiogenesis and accelerate wound healing in a mouse model and minimize scarring/gliosis following spinal cord injury. To evaluate the in vivo effects of CM101 on cutaneous wound healing in the pig,...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1023/a:1016752925761

    authors: Nanney LB,Wamil BD,Whitsitt J,Cardwell NL,Davidson JM,Yan HP,Hellerqvist CG

    更新日期:2001-01-01 00:00:00

  • The clinical application of angiostatic therapy in combination with radiotherapy: past, present, future.

    abstract::Although monotherapy with angiostatic drugs is still far from effective, there is abundant evidence that angiostatic therapy can improve the efficacy of conventional treatments like radiotherapy. This has instigated numerous efforts to optimize and clinically implement the combination of angiostatic drugs with radiati...

    journal_title:Angiogenesis

    pub_type: 历史文章,杂志文章,评审

    doi:10.1007/s10456-017-9546-9

    authors: Hamming LC,Slotman BJ,Verheul HMW,Thijssen VL

    更新日期:2017-05-01 00:00:00

  • Identification of HIF-2α-regulated genes that play a role in human microvascular endothelial sprouting during prolonged hypoxia in vitro.

    abstract::During prolonged hypoxic conditions, endothelial cells change their gene expression to adjust to the low oxygen environment. This process is mainly regulated by the hypoxia-inducible factors, HIF-1α and HIF-2α. Although endothelial cells do not form sprouts during prolonged hypoxic culturing, silencing of HIF-2α parti...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-016-9527-4

    authors: Nauta TD,van den Broek M,Gibbs S,van der Pouw-Kraan TC,Oudejans CB,van Hinsbergh VW,Koolwijk P

    更新日期:2017-02-01 00:00:00

  • Angiogenic desmoplastic histopathological growth pattern as a prognostic marker of good outcome in patients with colorectal liver metastases.

    abstract:BACKGROUND:In patients with resectable colorectal liver metastases (CRLM), distinct histopathological growth patterns (HGPs) develop at the interface between the tumour and surrounding tissue. The desmoplastic (d) HGP is characterised by angiogenesis and a peripheral fibrotic rim, whereas non-angiogenic HGPs co-opt end...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-019-09661-5

    authors: Galjart B,Nierop PMH,van der Stok EP,van den Braak RRJC,Höppener DJ,Daelemans S,Dirix LY,Verhoef C,Vermeulen PB,Grünhagen DJ

    更新日期:2019-05-01 00:00:00

  • GSK-3β: a signaling pathway node modulating neural stem cell and endothelial cell interactions.

    abstract::The neurogenic areas of the brain are highly organized structures in which there is dynamic reciprocal modulation of neural stem cells (NSC) and microvascular endothelial cells (BEC) resulting in control of neural stem cell and vascular proliferation, survival and differentiation throughout the life of the individual....

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-011-9201-9

    authors: Li Q,Michaud M,Canosa S,Kuo A,Madri JA

    更新日期:2011-05-01 00:00:00

  • Revascularization after angiogenesis inhibition favors new sprouting over abandoned vessel reuse.

    abstract::Inhibiting pathologic angiogenesis can halt disease progression, but such inhibition may offer only a temporary benefit, followed by tissue revascularization after treatment stoppage. This revascularization, however, occurs by largely unknown phenotypic changes in pathologic vessels. To investigate the dynamics of ves...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-019-09679-9

    authors: Mukwaya A,Mirabelli P,Lennikov A,Thangavelu M,Ntzouni M,Jensen L,Peebo B,Lagali N

    更新日期:2019-11-01 00:00:00

  • Identification of soluble CD146 as a regulator of trophoblast migration: potential role in placental vascular development.

    abstract::Both vasculogenesis and angiogenesis occur during normal placental vascular development. Additionally, the placenta undergoes a process of vascular mimicry (pseudo-vasculogenesis) where the placental extravillous trophoblast (EVT) that invade the spiral arteries convert from an epithelial to an endothelial phenotype d...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-012-9317-6

    authors: Kaspi E,Guillet B,Piercecchi-Marti MD,Alfaidy N,Bretelle F,Bertaud-Foucault A,Stalin J,Rambeloson L,Lacroix O,Blot-Chabaud M,Dignat-George F,Bardin N

    更新日期:2013-04-01 00:00:00

  • Transcriptional regulation of the vascular endothelial glycome by angiogenic and inflammatory signalling.

    abstract::Vascular endothelial cells undergo many molecular changes during pathological processes such as inflammation and tumour development. Tumours such as malignant lymphomas affecting bone marrow are dependent on interactions with endothelial cells for (1) site-specific homing and (2) tumour-induced angiogenesis. Modificat...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-010-9162-4

    authors: Willhauck-Fleckenstein M,Moehler TM,Merling A,Pusunc S,Goldschmidt H,Schwartz-Albiez R

    更新日期:2010-03-01 00:00:00

  • Oxidized phospholipids stimulate production of stem cell factor via NRF2-dependent mechanisms.

    abstract::Receptor tyrosine kinase c-Kit and its ligand stem cell factor (SCF) regulate resident vascular wall cells and recruit circulating progenitors. We tested whether SCF may be induced by oxidized palmitoyl-arachidonoyl-phosphatidylcholine (OxPAPC) known to accumulate in atherosclerotic vessels. Gene expression analysis d...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-017-9590-5

    authors: Afonyushkin T,Oskolkova OV,Bochkov VN

    更新日期:2018-05-01 00:00:00

  • Characterization of a drug-targetable allosteric site regulating vascular endothelial growth factor signaling.

    abstract::Vascular endothelial growth factors (VEGFs) regulate blood and lymph vessel development upon activation of three receptor tyrosine kinases (VEGFRs). The extracellular domain of VEGFRs consists of seven Ig-homology domains, of which D2-3 form the ligand-binding site, while the membrane proximal domains D4-7 are involve...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-018-9606-9

    authors: Thieltges KM,Avramovic D,Piscitelli CL,Markovic-Mueller S,Binz HK,Ballmer-Hofer K

    更新日期:2018-08-01 00:00:00

  • Angiogenesis in arthritis: role in disease pathogenesis and as a potential therapeutic target.

    abstract::Rheumatoid arthritis (RA) is a chronic destructive musculo-skeletal disorder, associated with thickening of the synovial membrane lining the joints, inflammation and hyperproliferation of synovial cells, as well as a pro-inflammatory cytokine cascade, leukocyte infiltration, and tissue damage and bone resorption. An e...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1023/a:1009229508096

    authors: Paleolog EM,Miotla JM

    更新日期:1998-01-01 00:00:00

  • Antiangiogenic therapy promoted metastasis of hepatocellular carcinoma by suppressing host-derived interleukin-12b in mouse models.

    abstract::Antiangiogenic therapy, specially sorafenib, has become the standard of care for patients with advanced hepatocellular carcinoma (HCC), however, the improvement in survival time is not satisfactory. Previous studies have found that, in some circumstances, antiangiogenic therapy promoted tumor metastasis and the mechan...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-013-9357-6

    authors: Zhu XD,Sun HC,Xu HX,Kong LQ,Chai ZT,Lu L,Zhang JB,Gao DM,Wang WQ,Zhang W,Zhuang PY,Wu WZ,Wang L,Tang ZY

    更新日期:2013-10-01 00:00:00

  • Semaphorin 4D cooperates with VEGF to promote angiogenesis and tumor progression.

    abstract::The semaphorins and plexins comprise a family of cysteine-rich proteins implicated in control of nerve growth and development and regulation of the immune response. Our group and others have found that Semaphorin 4D (SEMA4D) and its receptor, Plexin-B1, play an important role in tumor-induced angiogenesis, with some n...

    journal_title:Angiogenesis

    pub_type: 杂志文章,收录出版

    doi:10.1007/s10456-012-9268-y

    authors: Zhou H,Binmadi NO,Yang YH,Proia P,Basile JR

    更新日期:2012-09-01 00:00:00

  • NDRG1 and CRK-I/II are regulators of endothelial cell migration under Intermittent Hypoxia.

    abstract::Intermittent Hypoxia (IH) that develops in neovascularized solid tumours has been described to positively influence the tumour growth by modulating the behaviour of cancer cells as well as of endothelial cells. However, the molecular mechanisms regulated by IH still remain poorly understood. In this work, the effects ...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-009-9156-2

    authors: Toffoli S,Delaive E,Dieu M,Feron O,Raes M,Michiels C

    更新日期:2009-01-01 00:00:00